INTERPARFUMS INC IPAR

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived Nasdaq

Founded in 1982, we operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrances, and fragrance related products. Our worldwide headquarters and the office of our wholly owned United States subsidiary, Interparfums, USA LLC, are located at 551 Fifth Avenue, New York, New York 10176, and our telephone number is 212.983.2640. We also have wholly owned subsidiaries as follows:

Manufacture, market and distribute a wide array of prestige fragrances, and fragrance related products

Our consolidated majority owned subsidiary, Interparfums SA, maintains executive offices at 10 rue de Solférino, 75007 Paris, France. Our telephone number in Paris is 331.5377.0000. Interparfums SA also has wholly owned subsidiaries as follows:

Last close 115.22 2026-10-23
Market cap $3.69B 2026-06-30 share count
52-week range 77.21 - 129.29

Valuation FY2025 figures against the last close

P/S2.5x
P/E22.0x
P/FCF19.4x
EV/EBITDA12.6x
Dividend yield2.8%
Diluted EPS5.24

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.49B$1.45B$1.32B$1.09B$879.5M$539.0M$713.5M$95.1M$591.3M$521.1M
Cost of revenue $541.3M$525.0M$478.6M$392.2M$322.6M$208.3M$267.6M$248.0M$215.0M$194.6M
Gross profit $947.2M$927.3M$839.1M$694.4M$556.9M$330.7M$445.9M$427.6M$376.3M$326.5M
SG&A $676.9M$648.5M$587.7M$492.4M$406.5M$260.6M$341.2M$332.8M$295.5M$258.8M
Operating income $270.3M$274.8M$251.4M$194.3M$148.1M$70.1M$104.7M$94.7M$78.6M$66.7M
Interest expense $7.2M$7.8M$11.3M$3.6M$2.8M$2.0M$2.1M$2.6M$2.0M$2.3M
Pre-tax income $271.3M$268.4M$249.6M$194.2M$151.0M$69.3M$105.1M$95.9M$78.1M$67.1M
Income tax $63.2M$65.0M$61.8M$43.2M$41.0M$19.4M$29.1M$26.1M$22.8M$23.8M
Net income $208.0M$203.0M$188.0M$151.0M$110.0M$38.2M$60.2M$53.8M$41.6M$33.3M
EPS, basic 5.255.134.773.802.761.211.921.721.331.07
EPS, diluted 5.245.124.753.782.751.211.901.711.331.07
Shares, diluted (wtd. avg.) 32.1M32.1M32.1M32.0M31.8M31.7M31.7M31.52B31.3M31.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents ————$159.61B$169.7M$133.4M$193.1M$208.3M$161.8M
Short-term investments $137.1M$109.3M$94.3M$150.8M$160.0M$126.6M$119.7M$67.9M$69.9M$94.2M
Receivables $320.6M$274.7M$247.2M$197.6M$159.3M$124.1M$133.0M$133.3M$120.7M$104.8M
Inventory $351.4M$371.9M$371.9M$290.0M$198.9M$158.8M$167.8M$161.8M$137.1M$97.0M
Total current assets $1.03B$926.4M$839.0M$787.7M$709.7M$600.7M$573.3M$571.6M$549.3M$472.1M
Property, plant and equipment $184.9M$153.8M$169.2M$166.7M$149.4M$19.6M$11.1M$9.8M$10.3M$10.1M
Other intangibles $325.2M$282.5M$296.4M$290.9M$214.0M$214.1M$202.0M$204.3M$200.5M$183.9M
Total assets $1.59B$1.41B$1.37B$1.31B$1.15B$890.1M$828.8M$797.8M$777.8M$682.4M
Accounts payable $77.2M$91.0M$97.4M$88.4M$82.0M$35.6M$54.1M$58.3M$52.6M$49.5M
Short-term debt $54.8M$41.6M$29.6M$28.5M$15.9M$14.6M$12.3M$23.2M$24.4M$21.5M
Total current liabilities $344.0M$332.4M$324.7M$344.6M$244.9M$156.2M$184.5M$189.2M$167.1M$142.2M
Long-term debt $121.3M$115.7M$127.9M$151.5M$132.9M$10.1M$10.7M$22.9M$36.2M$53.1M
Retained earnings $828.9M$763.2M$693.8M$620.1M$560.7M$503.6M$474.6M$448.7M$422.6M$402.7M
Total equity $880.7M$744.9M$892.2M$788.1M$738.3M$702.5M$609.0M$585.7M$570.6M$483.7M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $214.9M$187.6M$105.8M$73.0M$119.6M$65.0M$76.5M$63.0M$35.9M$54.6M
Depreciation and amortisation $25.3M$28.4M$17.3M$22.5M$12.7M$9.1M$3.7M$4.1M$3.8M$3.7M
Stock-based compensation $1.6M$2.4M$2.5M$3.1M$2.9M$3.0M$3.4M$2.2M$2.1M$1.2M
Capital expenditure $24.4M$4.7M$6.5M$33.8M$141.3M$11.0M$5.4M$4.0M$3.0M$4.8M
Investing cash flow -$61.1M-$44.8M$7.3M-$90.6M-$187.9M-$22.3M-$64.6M-$13.6M$36.9M-$20.4M
Financing cash flow -$131.3M-$100.8M-$133.2M-$45.6M$78.2M-$18.6M-$68.2M-$55.9M-$47.6M-$44.6M
Dividends paid $102.7M$96.0M$80.0M$63.7M$31.7M$20.8M$34.6M$26.3M$21.2M$18.0M
Buybacks —————————$77.0K

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001753926-26-001295.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 500M 1B 1.5B Revenue, FY2016: 521.1M Gross profit, FY2016: 326.5M Net income, FY2016: 33.3M Revenue, FY2017: 591.3M Gross profit, FY2017: 376.3M Net income, FY2017: 41.6M Revenue, FY2018: 95.1M Gross profit, FY2018: 427.6M Net income, FY2018: 53.8M Revenue, FY2019: 713.5M Gross profit, FY2019: 445.9M Net income, FY2019: 60.2M Revenue, FY2020: 539M Gross profit, FY2020: 330.7M Net income, FY2020: 38.2M Revenue, FY2021: 879.5M Gross profit, FY2021: 556.9M Net income, FY2021: 110M Revenue, FY2022: 1.1B Gross profit, FY2022: 694.4M Net income, FY2022: 151M Revenue, FY2023: 1.3B Gross profit, FY2023: 839.1M Net income, FY2023: 188M Revenue, FY2024: 1.5B Gross profit, FY2024: 927.3M Net income, FY2024: 203M Revenue, FY2025: 1.5B Gross profit, FY2025: 947.2M Net income, FY2025: 208M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $521.1M $591.3M $95.1M $713.5M $539.0M $879.5M $1.09B $1.32B $1.45B $1.49B
Gross profit $326.5M $376.3M $427.6M $445.9M $330.7M $556.9M $694.4M $839.1M $927.3M $947.2M
Net income $33.3M $41.6M $53.8M $60.2M $38.2M $110.0M $151.0M $188.0M $203.0M $208.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $39.37B 217.3x 5.0%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
COTY COTY INC. $2.84B — -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.29B 52.9x -1.3%
WALD Waldencast plc $100.3M — -0.7%
SLSN SOLESENCE, INC. $56.5M 40.0x 18.6%